GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling
Analytical Cellular Pathology · 01.05.2021 · 2021 · 1-11
DOI: 10.1155/2021/5589532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, erschienen am 01.05.2021. Verfasst von Fan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006, China. Hauptthemen laut MEDLINE: Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Science and Technology Plan of Traditional Chinese Medicine, Medical Health Science and Technology Project of Zhejiang Provincial Health Commission, Zhejiang Provincial Science and Technology Program.
Abstract (Originalsprache)
The expression of G2 and S phase-expressed-1 (GTSE1) was upregulated in human cancer. However, its expression and roles in lung cancer have not been identified yet. In our study, we reported that GTSE1 expression was statistically higher in lung tissues than in the adjacent noncancerous tissues which might be a consequence of hypomethylation of the GTSE1 promoter. The upregulated expression of GTSE1 mRNA predicted the poorer survival of the lung patients. Ectopic expression of GTSE1 in lung cancer cells significantly increased while knockdown of GTSE1 decreased cell proliferation, cell migration, and cell invasion in H460 and A549 cells. Furthermore, knockdown of GTSE1 regulated the cell cycle and promoted cell apoptosis in H460 and A549 cells. Finally, we presented that GTSE1 was able to activate AKT/mTOR signaling in H460 and A549 cells. In conclusion, these results indicated that the overexpressed GTSE1 was involved in the progress of lung cancer by promoting proliferation migration and invasion and inhibiting apoptosis of lung cancer cells via activating AKT/mTOR signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, 310006, China.
- The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
ORCID-Profile: Wen Meng
Förderung
- Zhejiang Provincial Science and Technology Plan of Traditional Chinese Medicine
- Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
- Zhejiang Provincial Science and Technology Program
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhang, F., Meng, J., Jiang, H., Feng, X., Wei, D., & Meng, W. (2021). GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling. Analytical Cellular Pathology, 2021, 1-11. https://doi.org/10.1155/2021/5589532
Vancouver
Zhang F, Meng J, Jiang H, Feng X, Wei D, Meng W. GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling. Analytical Cellular Pathology. 2021;2021:1-11. doi:10.1155/2021/5589532
BibTeX
@article{Zhang2021,
author = {Zhang, Fan and Meng, Jingfei and Jiang, Hong and Feng, Xing and Wei, Dongshan and Meng, Wen},
title = {GTSE1 Facilitates the Malignant Phenotype of Lung Cancer Cells via Activating AKT/mTOR Signaling},
journal = {Analytical Cellular Pathology},
year = {2021},
volume = {2021},
pages = {1--11},
doi = {10.1155/2021/5589532}
}
EUVIMED